Contents of this filing
The corporate name will be changed from Japan Lifeline Co.,Ltd. to JLL Med Co., Ltd. The person authorized to convene and chair general meetings of shareholders and meetings of the Board of Directors will be changed from the Director-President to a director designated in advance by the Board of Directors. The provisions concerning the Representative Director and directors with specific titles will be revised, provisions concerning Executive Officers will be added, and the article numbers will be renumbered.
この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。
| Item | Details |
|---|---|
| Changes this time | The corporate name will be changed from Japan Lifeline Co.,Ltd. to JLL Med Co., Ltd. The person authorized to convene and chair general meetings of shareholders and meetings of the Board of Directors will be changed from the Director-President to a director designated in advance by the Board of Directors. The provisions concerning the Representative Director and directors with specific titles will be revised, provisions concerning Executive Officers will be added, and the article numbers will be renumbered. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to addressing the change in corporate name, the Company will separate the management decision-making and oversight functions from the business execution function and clarify their respective roles, thereby further strengthening the oversight function of the Board of Directors.